BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$3.64B |
| 2 |
Equinix
EQIX
|
+$2.21B |
| 3 |
Tesla
TSLA
|
+$2.19B |
| 4 |
SNDK
SANDISK CORP
SNDK
|
+$1.51B |
| 5 |
TRLA
TRULIA INC (DEL)
TRLA
|
+$1.5B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$277M |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$259M |
| 3 |
SPDR Gold Trust
GLD
|
+$231M |
| 4 |
Jakks Pacific
JAKK
|
+$231M |
| 5 |
Meta Platforms (Facebook)
META
|
+$157M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 21.52% |
| 3 | Consumer Discretionary | 8.65% |
| 4 | Financials | 5.92% |
| 5 | Real Estate | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
DuPont de Nemours
DD
$19.1B
| $34.2M | 0.03% |
270,345
-24,171
| -8% | -$2.85M |
|
202
iShares Core S&P 500 ETF
IVV
$904B
| $33.5M | 0.03% |
176,954
+160,266
| +960% | +$29.6M |
|
203
Exelon
EXC
$45.8B
| $32.7M | 0.03% |
1,307,950
-71,767
| -5% | -$1.51M |
|
|
ALXN
204
DELISTED
Alexion Pharmaceuticals
ALXN
| $32.6M | 0.03% |
205,945
-133,255
| -39% | -$21.2M |
|
|
PDCE
205
DELISTED
PDC Energy, Inc.
PDCE
| $32.4M | 0.03% |
200,000
+199,539
| +43,284% | +$10.9M |
|
206
PUT
iShares MSCI Emerging Markets ETF
EEM
$29.8B
| $32.2M | 0.03% |
82,179
-45,922
| -36% | -$1.8M |
|
207
State Street SPDR S&P Homebuilders ETF
XHB
$1.58B
| $31.9M | 0.02% |
1,030,070
+929,281
| +922% | +$30.2M |
|
|
DFS
208
DELISTED
Discover Financial Services
DFS
| $31.7M | 0.02% |
566,400
+307,245
| +119% | +$17.2M |
|
|
WBA
209
DELISTED
Walgreens Boots Alliance
WBA
| $31.6M | 0.02% |
465,889
+7,577
| +2% | +$476K |
|
210
iShares Russell 1000 Value ETF
IWD
$84.2B
| $31.5M | 0.02% |
323,752
+20,205
| +7% | +$1.89M |
|
211
Honeywell
HON
$77B
| $31.5M | 0.02% |
377,201
-41,617
| -10% | -$3.44M |
|
212
PUT
iShares China Large-Cap ETF
FXI
$4.35B
| $31.5M | 0.02% |
85,112
-35,631
| -30% | -$1.25M |
|
213
Applied Materials
AMAT
$415B
| $31.3M | 0.02% |
1,641,210
-526,540
| -24% | -$9.67M |
|
214
Abbott
ABT
$188B
| $31.2M | 0.02% |
806,651
-79,334
| -9% | -$3.06M |
|
215
Intuit
INTU
$91.5B
| $31M | 0.02% |
409,766
-217,674
| -35% | -$16.6M |
|
216
Medtronic
MDT
$114B
| $30.9M | 0.02% |
524,505
-100,315
| -16% | -$5.84M |
|
217
NextEra Energy
NEE
$177B
| $30.8M | 0.02% |
1,406,676
-25,020
| -2% | -$567K |
|
218
Eli Lilly
LLY
$1.1T
| $30.8M | 0.02% |
520,478
-8,220
| -2% | -$459K |
|
219
Cognizant
CTSH
$26.3B
| $30.7M | 0.02% |
641,608
-411,882
| -39% | -$20.6M |
|
220
PUT
Petrobras
PBR
$118B
| $29.6M | 0.02% |
106,699
+106,627
| +148,093% | +$1.24M |
|
221
Regeneron Pharmaceuticals
REGN
$83.2B
| $29M | 0.02% |
97,669
-63,684
| -39% | -$19.6M |
|
222
Emerson Electric
EMR
$88.5B
| $28.9M | 0.02% |
424,471
+61,376
| +17% | +$4.04M |
|
|
BRCM
223
DELISTED
BROADCOM CORP CL-A
BRCM
| $28.9M | 0.02% |
939,287
-27,450
| -3% | -$827K |
|
224
Morgan Stanley
MS
$338B
| $28.5M | 0.02% |
920,485
+102,321
| +13% | +$3.16M |
|
225
Capital One
COF
$134B
| $27.7M | 0.02% |
374,282
+51,229
| +16% | +$3.76M |
|
Similar funds
BNP Paribas Financial Markets's Q1 2014 Portfolio in Review
As of Q1 2014, BNP Paribas Financial Markets held 4,322 positions worth $129B, down 6.2% from $137B the previous quarter. Its ten largest holdings account for 38% of the portfolio.
BNP Paribas Financial Markets deployed $31.1B of net new capital in Q1 2014, opening 186 new positions and adding to 1,218 existing holdings. Its largest new stake was JOYY Inc: 14,000,000 shares worth $1.21B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
On the sell side, the largest reduction was Alphabet (Google) Class C, an estimated $277M trimmed.
- BNP Paribas Financial Markets's largest Q1 2014 buy was JOYY Inc: 14,000,000 shares worth $1.21B.
- BNP Paribas Financial Markets added most to Gilead Sciences in Q1 2014, an estimated $3.64B increase.
- BNP Paribas Financial Markets's biggest Q1 2014 reduction was Alphabet (Google) Class C, cutting an estimated $277M.
- BNP Paribas Financial Markets fully exited Jakks Pacific in Q1 2014, selling an estimated $231M.
- BNP Paribas Financial Markets's ten largest holdings make up 38% of its $129B portfolio in Q1 2014.
- BNP Paribas Financial Markets opened 186 new positions and closed 956 in Q1 2014.
- BNP Paribas Financial Markets's portfolio value fell 6.2% quarter-over-quarter to $129B.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2014, filed 13 May 2014.